Constellation Kidney Group Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Constellation Kidney Group and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 260 Constellation Kidney Group employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Constellation Kidney Group has purchased the following applications: Sales AI for CRM in 2024 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Constellation Kidney Group is running and its propensity to invest more and deepen its relationship with DeLorean Artificial Intelligence or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Constellation Kidney Group revenues, which have grown to $57.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Constellation Kidney Group intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DeLorean Artificial Intelligence | Legacy | Sales AI | CRM | CRM | n/a | 2024 | 2025 |
In 2024 Constellation Kidney Group integrated DeLorean Artificial Intelligence capabilities into its KidneyOne platform and implemented Sales AI as a CRM application. The deployment is centered on a clinical Renal AI integration for dialysis networks, and the extent of Sales AI CRM usage is not explicitly documented in available notes.
The implementation of Renal AI within KidneyOne produces predictive risk scores and care recommendations, delivering clinical decision support and care management prompts for dialysis clinical teams. Sales AI is identified as the CRM application name, and if adopted as part of DeLorean’s broader enterprise suite CRM functionality such as contact management, opportunity tracking, and workflow automation would align with the CRM category.
Integration work is explicitly between Renal AI and the KidneyOne platform for dialysis networks, with operational coverage described in North America and focused on clinical care pathways for dialysis patients. The solution’s outputs are consumed by care teams within KidneyOne workflows to inform patient risk stratification and care recommendations.
Governance and rollout details are limited in the source, however the partner reports reduced hospitalizations and improved care metrics linked to the Renal AI predictive risk scores and recommendations. The narrative positions Constellation Kidney Group Company 2024 Sales AI CRM relationship alongside a clinically driven Renal AI deployment, with clinical operations and care management as the primary business functions impacted.
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||